HLA-DR4 mice can be used to evaluate vaccine efficacies against Valley Fever.
Maintenance of body weight correlates with vaccine protection.
Early expansion of Th1 and Th17 cells before 9 dpc correlate with protection.
Persistence of adaptive immunity after 35 dpc associates with poor protection.